SCHEMBL19816945

SCHEMBL19816945

O=C(c1c[nH]c(=O)cc1-c1ccccc1)N1CCOCC1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
PLAUR Q03405 1/20 0.52
TSHR P16473 4/20 0.51
LMNA P02545 1/20 0.51
FNTA P49354 1/20 0.51
FNTB P49356 1/20 0.51
GAA P10253 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TP53 P04637 1/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
USP2 O75604 1/20 0.47
KDM4E B2RXH2 1/20 0.47
RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29465057 0.88 TSHR (0.61) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL29465023 0.85 SIGMAR1 (0.51) PLAURTSHRRECQL
SCHEMBL29857012 0.84 L3MBTL3 (0.49) TSHRLMNARAB9ARECQL
SCHEMBL19815809 0.84 L3MBTL1 (0.55) ALDH1A1CYP2C9TSHRLMNASMN1; SMN2
SCHEMBL3996738 0.79 TSHR (0.73) ALDH1A1CYP1A2CYP3A4CYP2C9PLAUR
SCHEMBL29857137 0.77 HRH4 (0.49) TSHRTP53RECQL
SCHEMBL19817301 0.75 PRKAB2 (0.54) ALDH1A1KDM4E
SCHEMBL7121916 0.73 SMN1; SMN2 (0.77) ALDH1A1TSHRGAASMN1; SMN2TP53
SCHEMBL7885342 0.73 ALDH1A1 (0.57) ALDH1A1CYP1A2CYP3A4CYP2C9PLAUR
SCHEMBL20181880 0.72 ALDH1A1 (0.75) ALDH1A1CYP1A2CYP3A4LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3890737-B1 USP19 INHIBITORS FOR USE IN A METHOD OF TREATING OBESITY, INSULIN RESISTANCE AND TYPE II DIABETES ALMAC DISCOVERY LTD (GB) 2024-06-05 EP claimed
EP-3490982-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2019-06-05 EP claimed
WO-2018020242-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2018-02-01 WO claimed
CN-109790146-B Pharmaceutical compounds 阿尔麦克探索有限公司 2022-08-23 CN disclosed